Condiciones de salud que ginseng puede ayudar a apoyar.
Panax ginseng has been used in Traditional Chinese Medicine for millennia to combat fatigue and stress. It supports adrenal function by modulating HPA axis activity and regulating cortisol, and may reduce the impact of chronic stress on the adrenal glands.
A 2025 randomized, double-blind, placebo-controlled trial (116 men with andropause symptoms) found ginseng berry extract (700 mg/day for 8 weeks) significantly improved Aging Male Symptoms (AMS) scores, ADAM questionnaire improvement rates, IIEF scores, and total testosterone versus placebo. Panax ginseng has extensive traditional use in East Asian medicine for male vitality and is among the most studied botanicals for andropause.
A systematic review and meta-analysis of RCTs (PubMed, Web of Science, Scopus, Cochrane through March 2023) evaluated ginseng's effects on oxidative stress biomarkers in humans. Ginsenosides are well-characterized antioxidant compounds that upregulate Nrf2/Keap1 signaling, stimulate SOD and glutathione peroxidase, and scavenge reactive oxygen species. The main bioactive ginsenosides include Rg1, Rg3, Rb1, and Re, each with documented antioxidant mechanisms.
A 2025 systematic review and meta-analysis (BMC Complementary Medicine and Therapies) of RCTs found ginseng supplementation improves endothelial function and reduces arterial stiffness as measured by PWV. Multiple meta-analyses also show ginseng lowers systolic and diastolic blood pressure. Ginsenosides are the key bioactive compounds with vasodilatory and anti-inflammatory effects on arterial walls.
A 12-week double-blind, placebo-controlled RCT in 90 postmenopausal women with osteopenia found that 3 g/day of ginseng extract significantly improved WOMAC arthritis index scores and knee arthritis symptoms, alongside improvements in bone formation markers. Ginsenosides possess documented anti-inflammatory properties relevant to joint inflammation. Clinical evidence remains preliminary, with few dedicated arthritis RCTs.
A 2024 systematic review (PubMed, Embase, Cochrane, Web of Science up to June 2023; 6 human studies) found that ginseng and ginsenosides may have beneficial effects on ADHD symptoms—particularly inattention—through dopaminergic and norepinephrinergic mechanisms. An observational clinical study in 18 children with ADHD (KRG 1,000 mg twice daily for 8 weeks) found significant improvements in omission errors and the Conners ADHD Rating Scale. Evidence quality remains limited by small samples and risk of bias.
Ginseng has documented in vitro platelet aggregation inhibitory effects via ginsenosides. However, RCTs show ginseng does not affect or may decrease warfarin's anticoagulant effect, and a case-crossover study showed no association with bleeding, reflecting complex and inconsistent antithrombotic activity in clinical settings.
A systematic review and meta-analysis published in the Journal of Human Hypertension (17 RCTs, n=1,381) evaluated ginseng's effect on blood pressure, finding modest but clinically relevant improvements particularly in individuals with cardiovascular risk factors such as diabetes, metabolic syndrome, and obesity. Red ginseng contains hypotensive compounds (ginsenoside Rg3, arginine-fructose) that stimulate endothelial nitric oxide release, promoting vasodilation. Results across trials are somewhat heterogeneous.
Ginseng extracts (particularly American ginseng, Panax quinquefolius, and Asian ginseng, Panax ginseng) have been clinically studied for blood sugar regulation. Multiple trials support anti-hyperglycemic, insulin-sensitizing, and islet-protective effects. Endotext (NCBI) lists American ginseng as having the best RCT evidence among natural products for blood glucose lowering.
Ginseng (Panax ginseng) is a widely studied adaptogenic herb with a millennia-long history in Traditional Chinese and Korean medicine for mental fatigue and cognitive clarity. Its active ginsenosides modulate HPA axis stress responses, neurotransmitter systems, and cerebral blood flow. Multiple RCTs demonstrate improvements in working memory, attention, and mental processing speed, particularly under conditions of fatigue.
Ginseng (Panax ginseng, American ginseng) has clinical evidence for reducing respiratory tract infections and improving respiratory immune function. A 2026 Nutrients review included ginseng-related compounds among clinically evaluated plant agents for RTIs. A double-blind RCT (323 adults) found American ginseng extract significantly reduced incidence and duration of respiratory illness. It is used in TCM for chronic bronchitis.
Panax ginseng has been studied for anti-fatigue and stress-related exhaustion in multiple RCTs and a systematic review. A 2020 systematic review and meta-analysis (8 RCTs, 30 animal studies) found Panax ginseng compounds superior to placebo on fatigue scales and heart rate recovery. An open-label study with standardized G115 extract in self-reporting fatigue adults found a 41.8% reduction in general fatigue at 90 days. Traditionally used in Chinese medicine for thousands of years to tonify qi and combat exhaustion.
Panax ginseng has been used in Traditional Chinese Medicine for over 2,000 years as an energy tonic and adaptogen. Modern research shows ginsenosides improve mitochondrial function, enhance ATP synthesis, activate AMPK, and reduce fatigue in both animal and human clinical studies.
Multiple systematic reviews and meta-analyses of RCTs have examined ginseng's effect on lipid profiles. A 2019 meta-analysis (18 RCTs) found 5 studies reported reductions in total cholesterol and 4 in LDL-cholesterol. However, a larger 2024 GRADE-assessed meta-analysis (29 RCTs) found no statistically significant overall influence on TG, TC, LDL-C, or HDL-C. Individual RCTs, particularly in metabolic syndrome populations, have shown reductions in total cholesterol, LDL, and triglycerides.
Panax ginseng has been used in East Asian medicine for thousands of years as a tonic for vitality and fatigue. A 2020 systematic review and meta-analysis of 8 RCTs found Panax ginseng compounds were superior to placebo on fatigue scales and heart rate recovery (p<0.05). A separate 2022 meta-analysis of disease-related fatigue RCTs also demonstrated anti-fatigue benefits.
Ginseng and its principal bioactive compounds, ginsenosides, have well-documented anti-inflammatory activity supported by mechanistic, preclinical, and some human/clinical evidence. Key ginsenosides (Rb1, Rg1, Rg3, Rh2, compound K) suppress chronic inflammatory signaling by downregulating NF-κB, reducing pro-inflammatory cytokines (TNF-α, IL-1β, IL-6), and inhibiting iNOS and COX-2. Human-relevant evidence spans rheumatic diseases, inflammatory bowel disease, and chronic respiratory conditions, though large-scale randomized controlled trials remain limited.
Multiple RCTs and a 2025 systematic review and meta-analysis (13 RCTs) demonstrate that ginseng supplementation improves flow-mediated dilation (FMD) and endothelial nitric oxide (eNO) production, key markers of vascular function. Ginsenosides, particularly Rg3, stimulate endothelial eNOS via the PI3K/Akt pathway, promoting vasodilation and inhibiting platelet aggregation. Clinical evidence also suggests reductions in arterial stiffness and improved coronary blood flow, though large-scale cardiovascular outcome trials remain sparse.
There is human clinical evidence—from randomized controlled trials and multiple systematic reviews—supporting Panax ginseng's modest benefit on memory and cognition, particularly in individuals with mild cognitive impairment (MCI) or Alzheimer's disease (AD). A 2024 meta-analysis of 15 RCTs found a statistically significant effect on memory improvement, especially at higher doses. However, a Cochrane review concluded that convincing evidence for a generalizable cognitive-enhancing effect is still lacking, and overall clinical evidence quality remains heterogeneous. Ginseng has also been used in traditional East Asian medicine for thousands of years to address aging and memory impairment.
Both Panax ginseng and Panax quinquefolius have been studied for cold and flu prevention. Several RCTs found North American ginseng extract (COLD-fX/CVT-E002) reduced cold frequency and duration. Evidence is described as inconsistent by NCCIH but some RCTs show benefit, particularly for prevention. ConsumerLab notes preliminary evidence that ginseng may reduce flu infection risk and enhance flu vaccine effectiveness.
Panax ginseng has been used in traditional Chinese medicine for respiratory conditions for millennia and has documented preclinical and early clinical evidence in COPD. Korean Red Ginseng extract and ginsenosides inhibit MAPK/NF-κB/c-Fos inflammatory pathways in lung models. Multiple small controlled clinical trials showed promising effects on COPD symptoms and quality of life, prompting a registered RCT (RMIT University/Austin Hospital).
Ginseng and its ginsenosides have been studied for depression-related outcomes in clinical trials and systematic reviews. Ginsenosides modulate HPA axis activity, neurotransmitter systems, and neuroinflammation. A 2021 meta-analysis found ginsenoside supplementation significantly improved depressive symptoms in clinical populations.
Korean red ginseng (KRG) has been evaluated in a double-blind RCT (n=100) for dry mouth. While the overall population showed no significant benefit, subgroup analysis found KRG significantly improved dry mouth VAS in menopausal women (ages 40–59) at 4 and 8 weeks. TCM also uses American and Asian ginseng to nourish yin and restore fluid generation in dry mouth.
Panax ginseng (Asian/Korean ginseng) is a classical adaptogen with clinical evidence for perceived stress reduction, improved emotional processing, and HPA axis modulation. A 2025 RCT (n=149, 200 mg/day, 3 weeks) in moderately stressed adults evaluated perceived stress and emotional abilities. Ginsenosides modulate serotonin, dopamine, GABA, and stress-response pathways.
Panax ginseng has been used for over 2,000 years in Traditional Chinese Medicine to restore vitality and reduce fatigue. A systematic review and meta-analysis of RCTs found Panax ginseng compounds (PGC) were superior to placebo for fatigue outcomes, heart rate recovery, and clinical effect. It is recognized in European herbal monographs for tiredness and weakness.
Panax (Korean red) ginseng is among the most clinically studied natural treatments for erectile dysfunction. A systematic review of 7 RCTs (n=349) published in BJC Pharmacology (2008) showed a significant effect vs placebo (risk ratio 2.40; 95% CI 1.65–3.51, p<0.00001). A subsequent meta-analysis of 5 RCTs (n=369) confirmed significantly improved IIEF scores (pooled MD=2.67, p=0.0009).
Panax ginseng has centuries of use in East Asian medicine as a male reproductive tonic. An RCT (n=90 infertile men) found standardized ginseng extract 1,800 mg/day for 12 weeks significantly improved sperm count, motility, and testosterone vs. placebo. Ginsenosides enhance NO production, support Leydig cell testosterone synthesis, and protect testicular tissue from oxidative stress.
Panax ginseng has been used for millennia in Traditional Chinese Medicine for mental vitality and clarity. Clinical RCTs report improvements in attention, working memory, and cognitive processing speed, particularly in mildly cognitively impaired or stressed individuals. A 2025 RCT in stressed adults found improvements in cognitive function and attention; evidence in healthy non-stressed adults is mixed.
Ginseng and ginsenosides have been identified in a systematic review of nutritional supplementation for glaucoma as one of the key herbs studied. Ginsenosides exhibit neuroprotective and antioxidant effects on retinal ganglion cells in preclinical models of elevated IOP.
Ginseng (Panax ginseng) ginsenosides have been shown to stimulate GLP-1 secretion from human enteroendocrine cells. The gintonin-enriched fraction stimulates GLP-1 secretion via the LPA6 receptor in human L-cells, and ginsenoside compound K was shown to stimulate GLP-1 in vitro.
Panax ginseng-containing traditional formula (Saengmaeksan) ameliorated hyperuricemia in animal studies by inhibiting xanthine oxidase activity and enhancing urate excretion. Ginsenosides also exhibit anti-inflammatory activity via NLRP3 inflammasome suppression. The MDPI 2024 review of herbal medications for gout includes Panax ginseng among evidence-supported herbs.
Ginseng (primarily Panax ginseng) has been studied for hair growth promotion in vitro, in animal models, and in limited human data. Ginsenosides promote hair follicle cell viability, inhibit apoptosis in dermal papilla cells, and extend the anagen phase. A 2015 PMC study found red ginseng extract promoted anagen maintenance in cultured human hair follicles.
Panax ginseng and its ginsenosides have demonstrated hair growth-promoting effects by preventing apoptosis of dermal papilla cells, inhibiting 5-alpha reductase, and activating the Wnt/beta-catenin pathway. Korean red ginseng extract has been studied in RCTs for alopecia areata. A mini-review of ginseng RCTs in postmenopausal women reported 20–40% follicle proliferation via ginsenosides.
Ginseng has been used in Traditional Chinese Medicine for millennia as an anti-aging 'tonic' herb. A 2017 PMC review (Aging and Disease) synthesized evidence showing ginsenosides prolong lifespan, support cardiovascular, nervous, and immune systems, and reduce oxidative stress and inflammation. Clinical trials document improvements in cognition, fatigue, and immune function in older adults.
Ginseng (Panax ginseng) has documented clinical and preclinical evidence supporting cardiovascular benefits, primarily through its active compounds called ginsenosides. Human RCT meta-analyses show modest but statistically significant reductions in systolic blood pressure, LDL cholesterol, total cholesterol, and inflammatory markers (CRP, IL-6). Vascular function meta-analyses also show improved flow-mediated dilation and endothelial nitric oxide levels. Evidence strength is moderate; many individual trials are small and short-term, and not all endpoints reach significance across all reviews.
A 2022 systematic review of 15 placebo-controlled RCTs found ginseng significantly reduced hot flash scores (SMD: −0.34, 95% CI: −0.66 to −0.01) and overall menopausal symptom burden in postmenopausal women. However, effects on hot flash frequency specifically, hormone levels, and endometrial thickness were not consistently demonstrated. Evidence quality is rated low to moderate due to risk of bias in the included studies.
Panax ginseng is a canonical adaptogen with documented HPA axis-modulating properties. Its ginsenosides modulate the CRH/ACTH/cortisol cascade, suppress adrenal catecholamine release under stress, and normalize glucocorticoid receptor sensitivity. Used in TCM for over 2,000 years, multiple clinical trials confirm its stress-axis and fatigue benefits.
Ginseng has been used in TCM and Native American medicine for centuries as a blood sugar regulator. A meta-analysis of 16 RCTs found ginseng significantly reduced fasting blood glucose (-0.31 mmol/L) versus placebo. American ginseng reduced postprandial glucose by 20% in a double-blind RCT in both diabetic and non-diabetic subjects. The PMC review on hypoglycemic herbs cites ginseng as a primary evidence-based hypoglycemic plant.
Ginseng, particularly American ginseng (Panax quinquefolius) and Asian ginseng (Panax ginseng), has been studied as an insulin sensitizer. The NIH Endotext explicitly lists American ginseng among insulin sensitizers studied in diabetes patients. Ginsenosides improve insulin secretion, reduce insulin resistance, and improve postprandial glucose control in clinical trials.
Ginseng (Panax ginseng) is a foundational tonic in East Asian traditional medicine used for thousands of years to enhance mental function and memory. Clinical RCTs show improvements in working memory and cognitive function in healthy adults and those with MCI. Ginsenosides modulate cholinergic transmission, increase long-term potentiation, and exert neuroprotective effects.
Panax ginseng (Korean/Asian red ginseng) has the strongest single-agent evidence base among herbal supplements for male erectile dysfunction and libido. Multiple RCTs and a 2025 systematic review/meta-analysis of 14 RCTs found ginseng significantly improved IIEF scores, sexual desire, orgasmic function, and serum testosterone in men with ED. Its ginsenosides promote nitric oxide synthesis in penile endothelial cells.
Ginseng has been extensively studied for hepatoprotective effects. A 2020 meta-analysis of 14 RCTs (n=992) found no significant change in standard liver enzymes (ALT, AST, GGT, ALP) at conventional doses in healthy individuals, but a 2025 systematic review highlights ginseng's multi-target mechanisms in non-alcoholic fatty liver disease (NAFLD), including reduction of lipid accumulation and oxidative stress. Preclinical and some clinical evidence supports hepatoprotective activity in those with liver disease, though robust human trial data remain limited.
Panax ginseng has been used in TCM for respiratory support and is the most commonly used traditional herb (32.5% usage frequency) in lung cancer treatment plans. Clinical and preclinical evidence shows ginsenosides reduce airway inflammation, improve exercise capacity in COPD, and modulate lung immune response.
Panax ginseng (red ginseng) ginsenosides inhibit 5α-reductase, stimulate dermal papilla cell proliferation, and improve scalp microcirculation. PMC reviews (PMC9963650, PMC11549889) cite red ginseng extract among phytochemicals with documented beneficial effects in AGA. A clinical study showed significant improvement in hair density with topical red ginseng application in AGA patients over 90–270 days.
Panax ginseng has been used in traditional Chinese and Korean medicine for millennia for memory, cognitive vitality, and combating mental fatigue. Multiple RCTs demonstrate improvements in working memory, attention, and cognitive performance in healthy adults. Active ginsenosides modulate acetylcholine, dopamine, and BDNF signaling. Typical studied dose is 200–400 mg/day of standardized extract.
Korean red ginseng is the most studied form for menopause; a 2024 review found it may improve overall menopausal symptoms and quality of life. It appears to benefit mood and sleep but has not consistently reduced vasomotor symptoms (hot flashes) in RCTs. It is also traditionally used in East Asian medicine for reproductive health and vitality in older women.
Panax ginseng has a multi-century history of use in Traditional Chinese Medicine for enhancing mental vitality and stamina. Controlled clinical trials support improvements in attention, mental arithmetic, processing speed, and mood in healthy adults.
Multiple human clinical trials and systematic reviews support ginseng—particularly Korean Red Ginseng (KRG)—as beneficial across several components of metabolic syndrome, including hyperglycemia, dyslipidemia, hypertension, and obesity. An umbrella review (Frontiers in Pharmacology, 2023) found moderate-quality evidence that ginseng reduces total cholesterol, triglycerides, and LDL-C in metabolic syndrome patients versus placebo. A 2021 PMC-indexed review (Food Science & Nutrition) concluded that ginseng can control metabolic syndrome via antihyperglycemic, antihyperlipidemic, antihypertensive, and anti-obesity mechanisms. Overall evidence quality is moderate at best, and larger, longer-duration RCTs are still needed.
Ginsenosides from Panax ginseng have been shown to activate AMPK/PGC-1α-mediated mitochondrial biogenesis and improve ETC Complex activities. Human RCTs demonstrate improved fatigue, physical performance, and cognitive function consistent with enhanced mitochondrial energy production. Traditionally used in Chinese medicine for over 2,000 years for energy and vitality.
Clinical evidence from RCTs shows that Korean red ginseng extract reduces post-exercise markers of muscle damage, specifically creatine kinase (CK) and interleukin-6 (IL-6), following uphill treadmill exercise. A systematic review of 14 clinical trials found mixed results on antioxidant function (SOD, MDA) and largely no improvement in peak aerobic or anaerobic performance. Ginseng's anti-inflammatory effects via NF-κB pathway inhibition are proposed as the primary recovery mechanism.
Ginseng (Panax ginseng) appears in approximately 28.6% of Chinese herbal medicine formulae for MG identified across 14 high-quality RCTs in a systematic review involving 1,039 patients. Ginsenoside Rb1, its most abundant active compound, was shown in a rat EAMG model to markedly ameliorate MG symptoms and modulate Th17/Treg immune balance and anti-AChR antibody titers.
Ginseng (Panax ginseng) has centuries of use in Traditional Chinese Medicine to tonify the nervous system and enhance mental function. Ginsenosides—the primary active compounds—modulate multiple neurotransmitter systems, support neuroplasticity, and clinical trials document cognitive and neuroprotective benefits.
Panax ginseng's ginsenosides (Rg1, Rb1) are the primary agents responsible for BDNF modulation, as established by the 2017 Neural Plasticity peer-reviewed review. Ginsenosides also modulate dopaminergic/noradrenergic signaling and have demonstrated cognitive enhancement and neuroprotection in preclinical and clinical studies.
Panax ginseng ginsenosides stimulate eNOS in vascular endothelial cells via PI3K-Akt and AMPK signaling, increasing NO production. Systematic reviews of clinical trials confirm ginseng improves erectile function and vascular biomarkers through NO-mediated mechanisms, consistent with its multi-millennial cardiovascular use in Asian traditional medicine.
Ginseng (Panax ginseng, Asian/Korean) has been evaluated in multiple RCTs for menopausal symptoms. A systematic review found ginseng may improve hot flashes and quality of life in menopausal women. It is particularly noted for psychological symptoms and sleep. However, evidence for vasomotor symptom reduction is limited.
Panax ginseng is the most-studied herb for human physical performance, with controlled studies showing improved exercise endurance when using standardized root extracts (>8 weeks, >1 g/day) in older subjects. A 2020 double-blind RCT found 200 mg extract significantly increased endurance, lowered heart rate, and reduced perceived exertion in endurance athletes. A 2025 systematic review and meta-analysis further confirmed its role in exercise endurance.
Ginseng (Panax ginseng) is cited in authoritative phytotherapy reviews as showing promise for respiratory diseases including pneumonia, with ginsenosides demonstrating immunomodulatory and antiviral properties. RCTs have studied Korean red ginseng for prevention of respiratory infections. Traditional East Asian medicine has used ginseng for lung deficiency and respiratory conditions for over 2,000 years.
Panax ginseng has millennia of use in TCM and Korean traditional medicine as a tonic for post-illness fatigue, debility, and restoration of vitality. A 2022 meta-analysis of 12 RCTs (1,298 patients) found ginseng significantly reduced disease-related fatigue. Ginsenosides modulate energy metabolism, antioxidant pathways, and NK cell activity.
Panax ginseng has multiple RCTs and a 2020 systematic review demonstrating anti-fatigue efficacy, and is specifically prescribed in long COVID treatment formulas as a 'monarch drug' in TCM-based recovery protocols. A 2024 systematic review confirmed ginseng and Astragalus as the most frequently used herbs for post-viral fatigue. The VA Long COVID guide (2023) includes Panax ginseng for fatigue and post-exertional malaise.
Korean red ginseng (Panax ginseng) was studied in a randomized double-blind placebo-controlled trial (Park et al., J Ethnopharmacol 2014, PMID 25284751) for cold hypersensitivity in the hands and feet — a condition overlapping with Raynaud's — and demonstrated significantly increased skin temperature, reduced discomfort, and improved response to cold exposure versus placebo. ConsumerLab and the Raynaud's Association cite this as evidence relevant to Raynaud's phenomenon. Traditional Korean medicine also uses ginseng for cold extremities and poor peripheral circulation.
Ginseng (Panax ginseng) and its bioactive ginsenosides have documented evidence for stimulating collagen synthesis in human dermal fibroblasts and protecting skin from UV-induced collagen degradation. Ginsenosides inhibit MMP-1 expression induced by UV radiation and upregulate type I procollagen synthesis. Both topical and oral ginseng preparations have clinical evidence for improving skin elasticity.
Panax ginseng is a classical TCM adaptogen with clinical evidence for stress reduction via HPA axis modulation. Its ginsenosides demonstrate cortisol-lowering and neuroendocrine-regulating effects in RCTs. Used for millennia in East Asian medicine to combat fatigue and restore balance.
Panax ginseng (Korean red ginseng) has been studied in clinical trials for testosterone-related outcomes, particularly in men with varicocele and metabolic syndrome. Some RCTs show modest testosterone increases via ginsenosides acting on the HPG axis. Systematic reviews note the evidence is limited and inconsistent across populations.
Ginseng (Panax ginseng and Panax quinquefolius) and its ginsenosides have been studied in multiple RCTs for lipid-lowering effects including triglyceride reduction. Meta-analyses show modest but significant TG reductions, particularly in T2D and metabolic syndrome patients.
North American ginseng (Panax quinquefolius, COLD-FX) has clinical evidence from double-blind RCTs showing significant reduction in cold incidence in elderly adults (10% vs. 22.8% in placebo, p=0.002). NCCIH cites inconsistent but supportive evidence for both Asian and North American ginseng for URTI prevention.
Ginseng (Panax ginseng) contains ginsenosides with clinically-studied immunomodulatory and antiviral properties. RCTs demonstrate that ginseng supplementation enhances NK cell activity, improves influenza vaccine immunogenicity, and reduces frequency and duration of colds and flu. It has been used for 2,000+ years in Traditional Chinese Medicine as an immune tonic.
Panax ginseng has a 2,000-year tradition in Chinese medicine for restoring vitality, reducing stress, and calming the mind. Modern evidence suggests anxiolytic effects via HPA axis modulation, serotonergic activity, and anti-inflammatory pathways. Clinical evidence for primary anxiety disorder is limited, but multiple trials show reduction in stress-related anxiety symptoms. Ginsenosides are the primary bioactive compounds.
Ginseng (Panax species) has been used for millennia in Traditional Chinese Medicine to improve stamina and vitality. The NIH ODS notes that while preparations have been used traditionally to improve physical performance, most rigorous clinical trials have found no significant ergogenic effect on peak power, VO2, or time to exhaustion.
Ginseng root is included as one of nine herbs in Sho-saiko-to-ka-kikyo-sekko (TJ-109), a traditional Kampo formula clinically studied for chronic tonsillitis. In TCM, ginseng tonifies Wei Qi (defensive energy) to prevent and address recurrent tonsillitis. Ginsenosides demonstrate immunomodulatory and anti-inflammatory activity relevant to tonsillar inflammation.
Volver